Cloning the Unclonable: Overcoming Challenges in Cell Line Development

Cloning the Unclonable: Overcoming Challenges in Cell Line Development Cell line development is key for biopharmaceutical production, cancer research, drug screening and functional gene studies. In this webinar, you’ll learn how researchers from Stanford University and the Lineberger Comprehensive Cancer Center have tackled tough challenges in cell line development. Our expert speaker will present case studies highlighting how poor cell viability and low editing efficiency of cells can be overcome while tracking and tracing clonality. Attend this webinar to discover: 1. Tips to maximize colony formation, even from sensitive cells 2. How to avoid isolation-induced alterations in cell response 3. A method to isolate cells with low or varying fluorescence Jessica Harman. PhD Sr. Director, Scientific Applications Cell Microsytems Dr. Jessica Hartman has a B.S in Biology from the University of Virginia, a Ph.D. from Duke University in Molecular Cancer Biology and postdoctoral training in Biochemistry and Cancer Biology at Baylor College of Medicine and Duke University, respectively. She has previously served in Director-level roles, managing bioscience research and development for biotechnology companies. At Cell Microsystems, Dr. Hartman’s role is to lead the development of new and streamlined workflows for scientific applications.